Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumors.

Abstract

Dysregulation of the protein kinase C (PKC) signaling pathway has been implicated in tumor progression. In this study, we investigate the effects of a PKC inhibitor, Enzastaurin, in human pancreatic neuroendocrine neoplasms (PNN) primary cultures and in the human pancreatic endocrine cancer cell line, BON1. To this aim six human PNN dispersed in primary cultures and BON1 cells were treated without or with 1-10 μM Enzastaurin and/or 100 nM IGF1 in the presence or absence of serum. Cell viability and apoptosis were evaluated after 48-72 h; Chromogranin A (CgA) and/or insulin secretion was assessed after 6 h of incubation. PKC expression was investigated by immunofluorescence and western blot. We found that Enzastaurin significantly reduced human PNN primary culture cell viability, as well as CgA and insulin secretion. Moreover, in the BON1 cell line Enzastaurin inhibited cell proliferation at 5 and 10 μM by inducing caspase-mediated apoptosis, and reduced phosphorylation of glycogen synthetase kinase 3β (GSK3β) and of Akt, both downstream targets of PKC pathway and pharmacodynamic markers for Enzastaurin. In addition, Enzastaurin blocked the stimulatory effect of IGF1 on cell proliferation, and reduced CgA expression and secretion in BON1 cells. Two different PKC isoforms are expressed at different levels and have partially different subcellular localization in BON1 cells. In conclusion, Enzastaurin reduces cell proliferation by inducing apoptosis, with a mechanism likely involving GSK3β signaling, and inhibits secretory activity in PNN in vitro models, suggesting that Enzastaurin might represent a possible medical treatment of human PNN.

• Authors: Daniela Molè, Teresa Gagliano, Erica Gentilin, Federico Tagliati, Claudio Pasquali, Maria Rosaria Ambrosio, Giancarlo Pansini, Ettore C Degli Uberti, Maria Chiara Zatelli
• Journal: Endocrine-related cancer (Endocr Relat Cancer) Vol. 18 Issue 4 Pg. 439-50 (Aug 2011) ISSN: 1479-6821 [Electronic] England
• PMID: 21606156 (Publication Type: Journal Article)

Chemical References

• CHGA protein, human
• Chromogranin A
• Indoles
• Insulin
• Protein Kinase C
• enzastaurin

Topics

• Apoptosis (drug effects)
• Blotting, Western
• Cell Proliferation (drug effects)
• Chromogranin A (metabolism)
• Enzyme-Linked Immunosorbent Assay
• Fluorescent Antibody Technique
• Humans
• Indoles (pharmacology)
• Insulin (metabolism)
• Insulin Secretion
• Neuroendocrine Tumors (drug therapy, enzymology, pathology)
• Pancreatic Neoplasms (drug therapy, enzymology, pathology)
• Protein Kinase C (antagonists & inhibitors, metabolism)
• Tumor Cells, Cultured